Clinical and biochemical predictors in patients with obesity and newly diagnosed type 2 diabetes mellitus
- Authors: Mikaelyan N.P1, Skripkina P.A1, Gaidina T.A1, Mikaelyan A.V2
-
Affiliations:
- Pirogov Russian National Research Medical University
- Moscow regional Clinical Research Institute. M.F. Vladimirsky
- Issue: Vol 22, No 5 (2019)
- Pages: 30-34
- Section: Articles
- URL: https://journals.eco-vector.com/1560-9596/article/view/112639
- DOI: https://doi.org/10.29296/25877313-2019-05-06
- ID: 112639
Cite item
Open Access
Access granted
Abstract
The aim of the study was to study some clinical and metabolic parameters in patients with insulin resistance in obesity and newly diagnosed type 2 diabetes mellitus. In 57 women aged 23 to 39 years with obesity 3-4 degrees and the first identified type 2 diabetes mellitus, the lipid composition of the erythrocyte membranes and the state of lipid peroxidation and antioxidant activity were studied. The control group consisted of 15 women without endocrine pathology. The study of biochemical predictors in patients with newly diagnosed diabetes mellitus type 2 and in patients with obesity, along with dyslipidemia, showed a violation of the composition of fatty acids in the blood due to the group of omega-3 and omega-6. Increased intensity lipid peroxidation on the background of reduced activity of antioxidants and the level of omega-3 fatty acids indicates the development of oxidative stress, the most pronounced in type 2 diabetes compared to obesity. The results of the study also indicate the presence of the antioxidant properties of omega-3 fatty acids, as evidenced by the direct correlation between omega-3 fatty acids and the activity of antioxidant enzymes. Conclusion: 1. In patients with diabetes mellitus type 2 and in patients with obesity, dyslipidemia, a violation of the composition of fatty acids are noted. 2. The development of oxidative stress, most pronounced in type 2 diabetes mellitus, was established. 3. Direct correlation relationships between omega-3 fatty acids and the activity of the studied enzymes indicate the presence of the antioxidant properties of omega-3 fatty acids.
Full Text
About the authors
N. P Mikaelyan
Pirogov Russian National Research Medical University
Email: ninmik@yandex.ru
Dr.Sc. (Biol.), Professor, Department of Biochemistry and Molecular Biology, Medical Faculty
P. A Skripkina
Pirogov Russian National Research Medical UniversityPh.D. (Med.), Associate Professor, Department of Dermatovenerology, Medical Faculty
T. A Gaidina
Pirogov Russian National Research Medical UniversityPh.D. (Med.), Associate Professor, Department of Dermatovenerology, Medical Faculty
A. V Mikaelyan
Moscow regional Clinical Research Institute. M.F. VladimirskyPh.D. (Med.), Associate Professor, Department of Obstetrics and Gynecology, Faculty of Advanced Training of Doctors
References
- Дедов И.И. Сахарный диабет: развитие технологий в диагностике, лечении и профилактики (пленарная лекция) // Сахарный диабет. 2010. Т. 3. № 48. С. 6-13.
- Булгакова С.В., Шафиева И.А., Кудлай Д.А. Факторы риска, как предикторы снижения минеральной плотности костной ткани у больных сахарным диабетом 2 типа старших возрастных групп // Аспирантский вестник Поволжья. 2016. № 1-2. С.68-74.
- Микаелян Н.П., Нгуен ЗХ., Терентьев А.А. Метаболические нарушения в мембранах эритроцитов и гомогенатах печеночной ткани при сахарном диабете в эксперименте. // БЭБиМ. 2015. № 2. С. 154-158.
- Harris W.S., Miller M., Tighe A.P., Davidson M.H., Schaefer E.J. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives // Atherosclerosis. 2008. № 197. Р. 12-24.
- Апухтин А.Ф., Стаценко М.Е., Инина Л.И. Сахароснижающий эффект ю3-полиненасыщенных жирных кислот у больных сахарным диабетом // Профилактическая медицина. 2012. Т. 15. № 6. С. 50-56.
- Rodriguez-Carrizalez A.D., Castellanos-Gonzalez J.A., Martmez-Romero E.C., Miller-Arrevillaga G., Villa-Hernandez D., Hernandez-Godinez P.P., Ortiz G.G., Pacheco-Moises F.P., Cardona-Munoz E.G., Miranda-Diaz A.G. Oxidants, antioxidants and mitochondrial function in non- proliferative diabetic retinopathy // J. Diabetes. 2014. V. 6. № 2. Р. 167-175.
- Микаелян Н.П., Гурина А.Е., Нгуен Х.З., Терентьев А.А., Микаелян К.А. Взаимосвязь между процессом пероксидации липидов и антиоксидантной системы от жирнокислотного состава крови у больных сахарным диабетом I типа и его осложнениях // РМЖ. 2014. С.33-39.
- Иванов Р., Секарёва Г., Кравцова О., Кудлай Д., Лукьянов С., Тихонова И., Дёмин А., Максумова Л., Никитина И., Обухов А., Зайцев Д., Степанов А., Носырева М., Самсонов М. Правила проведения исследований биоаналоговых лекарственных средств (биоаналогов) // Фармакокинетика и фармакодинамика. 2014. № 1. С. 21-36.
Supplementary files
